ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 280 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $202 | -79.2% | 6,672 | -80.7% | 0.00% | -100.0% |
| Q4 2023 | $972 | -24.6% | 34,615 | -27.1% | 0.00% | 0.0% |
| Q3 2023 | $1,289 | +57.2% | 47,512 | +78.0% | 0.00% | 0.0% |
| Q2 2023 | $820 | -97.7% | 26,696 | +2892.8% | 0.00% | – |
| Q3 2022 | $35,000 | -93.1% | 892 | -93.0% | 0.00% | -100.0% |
| Q4 2021 | $510,000 | +1086.0% | 12,798 | +1149.8% | 0.00% | – |
| Q3 2021 | $43,000 | -38.6% | 1,024 | -40.8% | 0.00% | – |
| Q2 2021 | $70,000 | +288.9% | 1,729 | +305.9% | 0.00% | – |
| Q1 2021 | $18,000 | +500.0% | 426 | +460.5% | 0.00% | – |
| Q2 2020 | $3,000 | – | 76 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $263,446,000 | 59.92% |
| Memorial Sloan Kettering Cancer Center | 1,128,255 | $43,957,000 | 50.90% |
| Vantage Consulting Group Inc | 2,727,854 | $106,277,000 | 41.47% |
| Indie Asset Partners, LLC | 756,874 | $29,488,000 | 22.15% |
| Overbrook Management Corp | 723,250 | $28,178,000 | 6.25% |
| Brown University | 621,759 | $24,224,000 | 5.93% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $8,527,000 | 3.82% |
| Lagoda Investment Management, L.P. | 141,560 | $5,515,000 | 2.97% |
| Greytown Advisors Inc. | 131,143 | $5,109,000 | 2.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,025,610 | $78,918,000 | 2.41% |